Not Signed In - Sifrol®/ Mirapexin® (pramipexole) Is First Treatment For Restless Legs Syndrome To Become Approved Throughout EU
Sat, 08 Apr 2006 11:00 PM EST
... Boehringer Ingelheim announced that the European Commission has approved Sifrol®/Mirapexin® (pramipexole) for the treatment of moderate to severe Restless Legs Syndrome (RLS) in the European Union. Pramipexole has been shown to provide clinically significant relief from the broad range of symptoms associated with RLS and is the first medication to be approved throughout the European Union for this indication... click link for more info. ...
Related Topics
- Restless Legs Syndrome
- Pramipexole
- Restless Legs Syndro
- Restless Leg Syndrome
- Tourette Syndrome
- Syndrome X
- Carpal Tunnel Syndrome
- Asperger's Syndrome
- Down Syndrome
- Marfan Syndrome
- Metabolic Syndrome
- Williams Syndrome
- Asperger Syndrome
- Klinefelter's Syndrome
- Nephrotic Syndrome
- Chronic Fatigue Syndrome
- Fragile X Syndrome
- Turner syndrome
- Fetal Alcohol Syndrome
- Cushings Syndrome
email this page
print this page
bookmark this page
feedback on this page
